汇宇制药：子公司产品获多个境外上市许可

Core Viewpoint - Seacross Pharma and Seacross Pharmaceuticals, subsidiaries of Huayu Pharmaceutical, have received marketing approvals for several injectable products from regulatory authorities in Turkmenistan, Spain, Italy, and the UK [1] Group 1 - The approved products include injectable pemetrexed disodium, injectable satraplatin, injectable cyclophosphamide, and injectable parecoxib sodium [1] - The approvals were granted by the respective drug regulatory agencies in Turkmenistan, Spain, Italy, and the UK [1]